Lori S Wenzel, MD | |
2769 Heartland Dr, Suite 201, Coralville, IA 52241-2732 | |
(319) 337-3193 | |
(319) 545-4570 |
Full Name | Lori S Wenzel |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2769 Heartland Dr, Coralville, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144214073 | NPI | - | NPPES |
0121673 | Medicaid | IA | |
160026347 | Other | IA | RAILROAD |
28139 | Other | IA | BC/BS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 30352 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lori S Wenzel, MD 2769 Heartland Dr, Suite 201, Coralville, IA 52241-2732 Ph: (319) 337-3193 | Lori S Wenzel, MD 2769 Heartland Dr, Suite 201, Coralville, IA 52241-2732 Ph: (319) 337-3193 |
News Archive
At present the Food and Drug Administration (FDA) is working with the Centers for Disease Control and Prevention (CDC) to determine the source of contaminated cantaloupe blamed for the nationwide Listeriosis outbreak. Several Colorado grocery stores have removed cantaloupe from shelves, though there has been no official recall.
Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles has specially been successful due to their structure.
Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
› Verified 9 days ago
Diane E. Adam, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2769 Heartland Dr, Suite 201, Coralville, IA 52241 Phone: 319-337-3173 Fax: 319-545-4570 | |
Mia D. Clevenger-hoeft, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2769 Heartland Dr, Suite 201, Coralville, IA 52241 Phone: 319-337-3193 Fax: 319-545-4570 | |
Dr. Allison M Boardman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 105 E 9th St, Coralville, IA 52241 Phone: 319-356-2294 Fax: 319-382-9693 | |
Jami L Shepard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2769 Heartland Dr, Suite 201, Coralville, IA 52241 Phone: 319-337-3193 Fax: 319-545-4570 | |
Jill C Goodman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2769 Heartland Dr, Suite 201, Coralville, IA 52241 Phone: 319-337-3139 Fax: 319-545-4570 |